Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Myeloproliferative Disorders
×
eltrombopag
×
Clear all
Filters
3
NCT01440374
2017-06-05
ASPIRE
Novartis
Phase 2
Completed
162 enrolled
24 charts